Earnings Call · Q3 FY2025·2025-11-12

Q3 25EPS +25.71%·Rev n/aQ2 25EPS +4.65%·Rev n/aQ1 25EPS +8.70%·Rev n/aQ4 24EPS +20.82%·Rev n/a⚠ consensus missing

Prelude Therapeutics Inc PRLD

Bryant Lim — Chief Financial Officer and Chief Legal Officer

Krishna Vaddi — Unknown

Peggy Scherle — Unknown

Sean Brusky — Unknown

+8.9%1d on move date+8.8% vs SPY3d+12.6%5d+24.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PRLD calls or request research access.

More PRLD calls Browse calls Request research access